Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 736 entries
Sorted by: Best Match Show Resources per page
Hippocampal subfield and medial temporal cortical persistent activity during working memory reflects ongoing encoding.

Frontiers in systems neuroscience

Nauer RK, Whiteman AS, Dunne MF, Stern CE, Schon K.
PMID: 25859188
Front Syst Neurosci. 2015 Mar 09;9:30. doi: 10.3389/fnsys.2015.00030. eCollection 2015.

Previous neuroimaging studies support a role for the medial temporal lobes in maintaining novel stimuli over brief working memory (WM) delays, and suggest delay period activity predicts subsequent memory. Additionally, slice recording studies have demonstrated neuronal persistent spiking in...

Cite
Nauer RK, Whiteman AS, Dunne MF, et al. Hippocampal subfield and medial temporal cortical persistent activity during working memory reflects ongoing encoding. Front Syst Neurosci. 2015;9:30doi: 10.3389/fnsys.2015.00030.
Nauer, R. K., Whiteman, A. S., Dunne, M. F., Stern, C. E., & Schon, K. (2015). Hippocampal subfield and medial temporal cortical persistent activity during working memory reflects ongoing encoding. Frontiers in systems neuroscience, 930. https://doi.org/10.3389/fnsys.2015.00030
Nauer, Rachel K, et al. "Hippocampal subfield and medial temporal cortical persistent activity during working memory reflects ongoing encoding." Frontiers in systems neuroscience vol. 9 (2015): 30. doi: https://doi.org/10.3389/fnsys.2015.00030
Nauer RK, Whiteman AS, Dunne MF, Stern CE, Schon K. Hippocampal subfield and medial temporal cortical persistent activity during working memory reflects ongoing encoding. Front Syst Neurosci. 2015 Mar 09;9:30. doi: 10.3389/fnsys.2015.00030. eCollection 2015. PMID: 25859188; PMCID: PMC4372545.
Copy Download .nbib Format: NLM
Legalization of recreational and medical marijuana: what we don't know.

Hospital pharmacy

Baker DE.
PMID: 24958934
Hosp Pharm. 2014 Apr;49(4):319-20. doi: 10.1310/hpj4904-319.

No abstract available.

Cite
Baker DE. Legalization of recreational and medical marijuana: what we don't know. Hosp Pharm. 2014;49(4):319-20doi: 10.1310/hpj4904-319.
Baker, D. E. (2014). Legalization of recreational and medical marijuana: what we don't know. Hospital pharmacy, 49(4), 319-20. https://doi.org/10.1310/hpj4904-319
Baker, Danial E. "Legalization of recreational and medical marijuana: what we don't know." Hospital pharmacy vol. 49,4 (2014): 319-20. doi: https://doi.org/10.1310/hpj4904-319
Baker DE. Legalization of recreational and medical marijuana: what we don't know. Hosp Pharm. 2014 Apr;49(4):319-20. doi: 10.1310/hpj4904-319. PMID: 24958934; PMCID: PMC4062740.
Copy Download .nbib Format: NLM
Medication counterfeiting.

Hospital pharmacy

Baker DE.
PMID: 25477589
Hosp Pharm. 2014 Sep;49(8):683-4. doi: 10.1310/hpj4908-683.

No abstract available.

Cite
Baker DE. Medication counterfeiting. Hosp Pharm. 2014;49(8):683-4doi: 10.1310/hpj4908-683.
Baker, D. E. (2014). Medication counterfeiting. Hospital pharmacy, 49(8), 683-4. https://doi.org/10.1310/hpj4908-683
Baker, Danial E. "Medication counterfeiting." Hospital pharmacy vol. 49,8 (2014): 683-4. doi: https://doi.org/10.1310/hpj4908-683
Baker DE. Medication counterfeiting. Hosp Pharm. 2014 Sep;49(8):683-4. doi: 10.1310/hpj4908-683. PMID: 25477589; PMCID: PMC4252192.
Copy Download .nbib Format: NLM
Dalbavancin.

Hospital pharmacy

Cada DJ, Ingram K, Baker DE.
PMID: 25477617
Hosp Pharm. 2014 Oct;49(9):851-61. doi: 10.1310/hpj4909-851.

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive...

Cite
Cada DJ, Ingram K, Baker DE. Dalbavancin. Hosp Pharm. 2014;49(9):851-61doi: 10.1310/hpj4909-851.
Cada, D. J., Ingram, K., & Baker, D. E. (2014). Dalbavancin. Hospital pharmacy, 49(9), 851-61. https://doi.org/10.1310/hpj4909-851
Cada, Dennis J, et al. "Dalbavancin." Hospital pharmacy vol. 49,9 (2014): 851-61. doi: https://doi.org/10.1310/hpj4909-851
Cada DJ, Ingram K, Baker DE. Dalbavancin. Hosp Pharm. 2014 Oct;49(9):851-61. doi: 10.1310/hpj4909-851. PMID: 25477617; PMCID: PMC4252189.
Copy Download .nbib Format: NLM
Intestinal Microbiota Signatures Associated with Inflammation History in Mice Experiencing Recurring Colitis.

Frontiers in microbiology

Berry D, Kuzyk O, Rauch I, Heider S, Schwab C, Hainzl E, Decker T, Müller M, Strobl B, Schleper C, Urich T, Wagner M, Kenner L, Loy A.
PMID: 26697002
Front Microbiol. 2015 Dec 15;6:1408. doi: 10.3389/fmicb.2015.01408. eCollection 2015.

Acute colitis causes alterations in the intestinal microbiota, but the microbiota is thought to recover after such events. Extreme microbiota alterations are characteristic of human chronic inflammatory bowel diseases, although alterations reported in different studies are divergent and sometimes...

Cite
Berry D, Kuzyk O, Rauch I, et al. Intestinal Microbiota Signatures Associated with Inflammation History in Mice Experiencing Recurring Colitis. Front Microbiol. 2015;6:1408doi: 10.3389/fmicb.2015.01408.
Berry, D., Kuzyk, O., Rauch, I., Heider, S., Schwab, C., Hainzl, E., Decker, T., Müller, M., Strobl, B., Schleper, C., Urich, T., Wagner, M., Kenner, L., & Loy, A. (2015). Intestinal Microbiota Signatures Associated with Inflammation History in Mice Experiencing Recurring Colitis. Frontiers in microbiology, 61408. https://doi.org/10.3389/fmicb.2015.01408
Berry, David, et al. "Intestinal Microbiota Signatures Associated with Inflammation History in Mice Experiencing Recurring Colitis." Frontiers in microbiology vol. 6 (2015): 1408. doi: https://doi.org/10.3389/fmicb.2015.01408
Berry D, Kuzyk O, Rauch I, Heider S, Schwab C, Hainzl E, Decker T, Müller M, Strobl B, Schleper C, Urich T, Wagner M, Kenner L, Loy A. Intestinal Microbiota Signatures Associated with Inflammation History in Mice Experiencing Recurring Colitis. Front Microbiol. 2015 Dec 15;6:1408. doi: 10.3389/fmicb.2015.01408. eCollection 2015. PMID: 26697002; PMCID: PMC4678223.
Copy Download .nbib Format: NLM
Oritavancin diphosphate.

Hospital pharmacy

Cada DJ, Baker DE.
PMID: 25673895
Hosp Pharm. 2014 Dec;49(11):1049-60. doi: 10.1310/hjp4911-1049.

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive...

Cite
Cada DJ, Baker DE. Oritavancin diphosphate. Hosp Pharm. 2014;49(11):1049-60doi: 10.1310/hjp4911-1049.
Cada, D. J., & Baker, D. E. (2014). Oritavancin diphosphate. Hospital pharmacy, 49(11), 1049-60. https://doi.org/10.1310/hjp4911-1049
Cada, Dennis J, and Baker, Danial E. "Oritavancin diphosphate." Hospital pharmacy vol. 49,11 (2014): 1049-60. doi: https://doi.org/10.1310/hjp4911-1049
Cada DJ, Baker DE. Oritavancin diphosphate. Hosp Pharm. 2014 Dec;49(11):1049-60. doi: 10.1310/hjp4911-1049. PMID: 25673895; PMCID: PMC4319806.
Copy Download .nbib Format: NLM
Investigation of the adsorption behaviour of acetone at the surface of ice. A grand canonical Monte Carlo simulation study.

Physical chemistry chemical physics : PCCP

Hantal G, Jedlovszky P, Hoang PN, Picaud S.
PMID: 18972025
Phys Chem Chem Phys. 2008 Nov 14;10(42):6369-80. doi: 10.1039/b808466a. Epub 2008 Sep 08.

The adsorption isotherm of acetone at the surface of I(h) ice has been determined by a set of grand canonical Monte Carlo simulations at 200 K, by varying the chemical potential of acetone in the simulations. The obtained isotherm...

Cite
Hantal G, Jedlovszky P, Hoang PN, et al. Investigation of the adsorption behaviour of acetone at the surface of ice. A grand canonical Monte Carlo simulation study. Phys Chem Chem Phys. 2008;10(42):6369-80doi: 10.1039/b808466a.
Hantal, G., Jedlovszky, P., Hoang, P. N., & Picaud, S. (2008). Investigation of the adsorption behaviour of acetone at the surface of ice. A grand canonical Monte Carlo simulation study. Physical chemistry chemical physics : PCCP, 10(42), 6369-80. https://doi.org/10.1039/b808466a
Hantal, György, et al. "Investigation of the adsorption behaviour of acetone at the surface of ice. A grand canonical Monte Carlo simulation study." Physical chemistry chemical physics : PCCP vol. 10,42 (2008): 6369-80. doi: https://doi.org/10.1039/b808466a
Hantal G, Jedlovszky P, Hoang PN, Picaud S. Investigation of the adsorption behaviour of acetone at the surface of ice. A grand canonical Monte Carlo simulation study. Phys Chem Chem Phys. 2008 Nov 14;10(42):6369-80. doi: 10.1039/b808466a. Epub 2008 Sep 08. PMID: 18972025.
Copy Download .nbib Format: NLM
[Doctoral setting in the nursing channel: more value and orientations in the context].

Recherche en soins infirmiers

Debout C, Chantal E, Rothan-Tondeur M.
PMID: 20419949
Rech Soins Infirm. 2010 Mar;(100):134-44.

No abstract available.

Cite
Debout C, Chantal E, Rothan-Tondeur M. Une formation doctorale dans la filière infirmière: plus value et orientations dans le contexte Français. [Doctoral setting in the nursing channel: more value and orientations in the context]. Rech Soins Infirm. 2010;(100):134-44
Debout, C., Chantal, E., & Rothan-Tondeur, M. (2010). Une formation doctorale dans la filière infirmière: plus value et orientations dans le contexte Français. [Doctoral setting in the nursing channel: more value and orientations in the context]. Recherche en soins infirmiers, (100), 134-44.
Debout, Christophe, et al. "Une formation doctorale dans la filière infirmière: plus value et orientations dans le contexte Français." [Doctoral setting in the nursing channel: more value and orientations in the context]. Recherche en soins infirmiers vol. ,100 (2010): 134-44.
Debout C, Chantal E, Rothan-Tondeur M. Une formation doctorale dans la filière infirmière: plus value et orientations dans le contexte Français. [Doctoral setting in the nursing channel: more value and orientations in the context]. Rech Soins Infirm. 2010 Mar;(100):134-44. French. PMID: 20419949.
Copy Download .nbib Format: NLM
Counterion and surface density dependence of the adsorption layer of ionic surfactants at the vapor-aqueous solution interface: a computer simulation study.

The journal of physical chemistry. B

Hantal G, Partay LB, Varga I, Jedlovszky P, Gilányi T.
PMID: 17263573
J Phys Chem B. 2007 Feb 22;111(7):1769-74. doi: 10.1021/jp066969c. Epub 2007 Jan 31.

To test the validity of currently used adsorption theories and understand the origin of the lack of their ability of adequately describing existing surface tension measurement data, we have performed a series of molecular dynamics simulations of the adsorption...

Cite
Hantal G, Partay LB, Varga I, et al. Counterion and surface density dependence of the adsorption layer of ionic surfactants at the vapor-aqueous solution interface: a computer simulation study. J Phys Chem B. 2007;111(7):1769-74doi: 10.1021/jp066969c.
Hantal, G., Partay, L. B., Varga, I., Jedlovszky, P., & Gilányi, T. (2007). Counterion and surface density dependence of the adsorption layer of ionic surfactants at the vapor-aqueous solution interface: a computer simulation study. The journal of physical chemistry. B, 111(7), 1769-74. https://doi.org/10.1021/jp066969c
Hantal, György, et al. "Counterion and surface density dependence of the adsorption layer of ionic surfactants at the vapor-aqueous solution interface: a computer simulation study." The journal of physical chemistry. B vol. 111,7 (2007): 1769-74. doi: https://doi.org/10.1021/jp066969c
Hantal G, Partay LB, Varga I, Jedlovszky P, Gilányi T. Counterion and surface density dependence of the adsorption layer of ionic surfactants at the vapor-aqueous solution interface: a computer simulation study. J Phys Chem B. 2007 Feb 22;111(7):1769-74. doi: 10.1021/jp066969c. Epub 2007 Jan 31. PMID: 17263573.
Copy Download .nbib Format: NLM
Unconventional solution: a marketing approach to solving health literacy disparities.

Pediatrics

Leiner M, Handal G.
PMID: 17974756
Pediatrics. 2007 Nov;120(5):1218-9; author reply 1219-20. doi: 10.1542/peds.2007-2366.

No abstract available.

Cite
Leiner M, Handal G. Unconventional solution: a marketing approach to solving health literacy disparities. Pediatrics. 2007;120(5):1218-9; author reply 1219-20doi: 10.1542/peds.2007-2366.
Leiner, M., & Handal, G. (2007). Unconventional solution: a marketing approach to solving health literacy disparities. Pediatrics, 120(5), 1218-9; author reply 1219-20. https://doi.org/10.1542/peds.2007-2366
Leiner, Marie, and Handal, Gilbert. "Unconventional solution: a marketing approach to solving health literacy disparities." Pediatrics vol. 120,5 (2007): 1218-9; author reply 1219-20. doi: https://doi.org/10.1542/peds.2007-2366
Leiner M, Handal G. Unconventional solution: a marketing approach to solving health literacy disparities. Pediatrics. 2007 Nov;120(5):1218-9; author reply 1219-20. doi: 10.1542/peds.2007-2366. PMID: 17974756.
Copy Download .nbib Format: NLM
Certolizumab pegol for the treatment of Crohn's disease.

Expert review of clinical immunology

Baker DE.
PMID: 20477691
Expert Rev Clin Immunol. 2009 Nov;5(6):683-91. doi: 10.1586/eci.09.48.

Certolizumab pegol is a polyethylene glycolated FAb' fragment of a humanized anti-TNF-alpha monoclonal antibody. This pegylated molecule binds with circulating TNF-alpha and forms an inactive complex that is then eliminated from the body. The drug has been shown to...

Cite
Baker DE. Certolizumab pegol for the treatment of Crohn's disease. Expert Rev Clin Immunol. 2009;5(6):683-91doi: 10.1586/eci.09.48.
Baker, D. E. (2009). Certolizumab pegol for the treatment of Crohn's disease. Expert review of clinical immunology, 5(6), 683-91. https://doi.org/10.1586/eci.09.48
Baker, Danial E. "Certolizumab pegol for the treatment of Crohn's disease." Expert review of clinical immunology vol. 5,6 (2009): 683-91. doi: https://doi.org/10.1586/eci.09.48
Baker DE. Certolizumab pegol for the treatment of Crohn's disease. Expert Rev Clin Immunol. 2009 Nov;5(6):683-91. doi: 10.1586/eci.09.48. PMID: 20477691.
Copy Download .nbib Format: NLM
STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

The Journal of experimental medicine

Goldblatt H, Lynch J, Hanzal RF, Summerville WW.
PMID: 19870251
J Exp Med. 1934 Feb 28;59(3):347-79. doi: 10.1084/jem.59.3.347.

These experiments indicate that, in dogs at least, ischemia localized to the kidneys is a sufficient condition for the production of persistently elevated systolic blood pressure. When the constriction of both main renal arteries is made only moderately severe...

Cite
Goldblatt H, Lynch J, Hanzal RF, et al. STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA. J Exp Med. 1934;59(3):347-79doi: 10.1084/jem.59.3.347.
Goldblatt, H., Lynch, J., Hanzal, R. F., & Summerville, W. W. (1934). STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA. The Journal of experimental medicine, 59(3), 347-79. https://doi.org/10.1084/jem.59.3.347
Goldblatt, H, et al. "STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA." The Journal of experimental medicine vol. 59,3 (1934): 347-79. doi: https://doi.org/10.1084/jem.59.3.347
Goldblatt H, Lynch J, Hanzal RF, Summerville WW. STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA. J Exp Med. 1934 Feb 28;59(3):347-79. doi: 10.1084/jem.59.3.347. PMID: 19870251; PMCID: PMC2132360.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 736 entries